Your first dose of Mounjaro: what actually happens

Why 2.5 mg — and what that first pen is actually doing

A lot of people open the box expecting dramatic results from day one. The 2.5 mg pen is doing something more modest: it is settling your system into the medicine. Tirzepatide (the active ingredient in Mounjaro) slows gastric emptying and acts on two gut-hormone receptors simultaneously. That is a meaningful physiological shift, and starting gently is how the prescribing schedule is designed to minimise early nausea and discomfort.

According to the NHS patient information for tirzepatide, treatment begins at 2.5 mg weekly, with dose increases reviewed by your prescriber at roughly four-week intervals. The timing is not arbitrary. Rushing upward before your body has adjusted is how people run into avoidable side effects. Think of the first pen not as the treatment in full, but as the opening chapter of a longer clinical plan.

The KwikPen itself contains four weekly doses. When it arrives (delivered in plain, unmarked packaging with a DPD tracking notification to your phone) the pen goes straight into the fridge at 2°C to 8°C. Each dose is drawn at the same time each week. Exact storage details are in the Patient Information Leaflet; the broad principle is consistent refrigeration until you are ready to inject.

If you want a clear overview of how doses progress through the schedule, the guide to Mounjaro dose progression covers each step in detail.

Where to inject and what the experience is like

The three licensed injection sites are the abdomen, the front or outer thigh, and the upper arm. Most people starting out find the abdomen the most straightforward to reach and control. The needle is very fine (Mounjaro's KwikPen is designed for ease of use) and many people describe the sensation as a brief pinch that is gone within seconds.

Rotate your injection site each week. Using the same spot repeatedly can cause localised skin reactions, which is uncomfortable and affects absorption. You do not need to use alcohol swabs before injecting, though some people prefer to, if you do, let the skin dry fully before the injection goes in.

Inject into fatty subcutaneous tissue; avoid areas that are bruised, tender, or show broken skin. Do not inject into muscle. If you are uncertain about technique, your prescriber and the detailed instructions in the Patient Information Leaflet are the right references, not general internet guides, which vary in accuracy.

Timing within the day is flexible. The once-weekly schedule matters; the specific hour does not. Many people pick a day and a rough time that fits their routine and stick to it. If you need to think through how dose timing affects what happens week to week, the page on your second Mounjaro dose covers the follow-through logically.

Side effects most likely to appear after the first dose

Gastrointestinal effects are the most common early experience: nausea, loose stools, constipation, indigestion, or a feeling of fullness that arrives faster than usual during meals. Most people who experience them describe them as mild to moderate and short-lived. They are most pronounced in the first week or two after starting or after a dose increase, and often ease as the body adapts.

Eating smaller portions, avoiding very fatty or heavily spiced food in the early weeks, and staying properly hydrated all help. Hunger cues change too, you may notice your appetite falls more sharply than expected, even on the lowest dose.

Injection-site redness or mild tenderness is also possible; rotating sites keeps this manageable. Headache, dizziness and fatigue appear less commonly.

Seek medical help promptly for severe or persistent abdominal pain that radiates to the back. The MHRA highlighted acute pancreatitis as an infrequent but serious risk associated with GLP-1 medicines, the Yellow Card scheme is where you can report any suspected side effects. Allergic reactions are rare but require immediate attention if they occur.

Missed doses, unusual symptoms and any questions about adjusting timing are always a conversation for your prescriber. The Patient Information Leaflet covers missed-dose guidance specifically.

When does the prescriber consider moving you beyond 2.5 mg?

After four weeks on 2.5 mg, a clinician reviews how you are tolerating the medicine and whether a dose increase is appropriate. This is not automatic. If side effects have been significant, staying at 2.5 mg for a further four weeks is a legitimate clinical choice. Equally, if tolerability has been good, moving to the Mounjaro 5 mg dose is the typical next step. The decision sits with your prescriber, not with a protocol that runs regardless of how you are feeling.

At nume, at nume, every repeat order is reviewed by a GPhC-registered Independent Prescriber before it is dispensed. Evidence of your current dose and your experience on it informs each decision. That includes dose increases: providing confirmation of your starting dose and how you have responded is part of the process. Detailed information on what guides dose progression is on the page covering when to increase your Mounjaro dose.

If you are weighing up the cost involved in treatment, the Mounjaro pricing page gives an honest breakdown of what private treatment typically costs in the UK and what an all-inclusive service should cover. Worth reading before you compare providers.

Suitability is confirmed through a clinical consultation. To check whether you are eligible and to speak with our prescribers, check your eligibility here.